These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14129855)

  • 1. ON THE PLASMINOGEN ACTIVATOR FORMING CAPACITY OF HUMAN PLASMA GLOBULINS REACTING WITH STREPTOKINASE.
    AUERSWALD W; DOLESCHEL W
    Med Exp Int J Exp Med; 1964; 10():179-84. PubMed ID: 14129855
    [No Abstract]   [Full Text] [Related]  

  • 2. MOLECULAR AND LYTIC PARAMETERS OF SERUM GLOBULINS REACTING WITH STREPTOKINASE.
    AUERSWALD W; DOLESCHEL W; VON LUETZOW ; SCHUBERT H
    Med Exp Int J Exp Med; 1964; 10():402-10. PubMed ID: 14186188
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research on fibrinolysis: the fibrinolysis factors in Kline's plasminogen].
    GIACOMAZZI G
    Haematol Lat; 1961; 4():339-70. PubMed ID: 13898267
    [No Abstract]   [Full Text] [Related]  

  • 4. FIBRINOLYSIS.
    ADAMIS D
    Conn Med; 1964 Sep; 28():662-7. PubMed ID: 14201318
    [No Abstract]   [Full Text] [Related]  

  • 5. ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS.
    AUERSWALD W; BERNHEIMER H; DOLESCHEL W
    Med Pharmacol Exp Int J Exp Med; 1965; 12():81-91. PubMed ID: 14279888
    [No Abstract]   [Full Text] [Related]  

  • 6. QUANTITATIVE ESTIMATION OF UROKINASE AND BACTERIAL PLASMINOGEN ACTIVATORS USING A FIBRIN SUBSTRATE FORMED FROM PLASMINOGEN-FREE FIBRINOGEN.
    ANDERSON AJ
    Biochim Biophys Acta; 1963 Aug; 74():554-7. PubMed ID: 14071603
    [No Abstract]   [Full Text] [Related]  

  • 7. THE EUGLOBULIN METHOD FOR ESTIMATION OF FIBRINOLYTIC ACTIVITY IN UROKINASE-ACTIVATED PLASMA, AND THE INFLUENCE OF TRASYLOL.
    BLIX S
    Scand J Clin Lab Invest; 1964; 16():198-200. PubMed ID: 14161857
    [No Abstract]   [Full Text] [Related]  

  • 8. THE FIBRINOLYTIC SYSTEM IN BLOOD AFTER RETENTION OF A DEAD FETUS AND DURING NORMAL LABOR.
    BRAKMAN P; KING AE
    Am J Obstet Gynecol; 1965 May; 92():221-6. PubMed ID: 14281832
    [No Abstract]   [Full Text] [Related]  

  • 9. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 10. THE QUANTITATIVE DETERMINATION OF FIBRINOLYTIC INHIBITORS IN PLASMA OR SERUM BY MEANS OF THE FIBRIN PLATE.
    BLIX S
    Scand J Clin Lab Invest; 1964; 16():403-8. PubMed ID: 14202020
    [No Abstract]   [Full Text] [Related]  

  • 11. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 12. FIBRINOLYTIC ACTIVITY OF TISSUE SECTIONS OF THE DOG KIDNEY.
    PROKOPOWICZ J; REJNIAK L; NIEWIAROWSKI S; WOROWSKI K
    Thromb Diath Haemorrh; 1964 Dec; 12():396-406. PubMed ID: 14254699
    [No Abstract]   [Full Text] [Related]  

  • 13. TREATMENT OF PERIPHERAL VASCULAR OCCLUSION BY STREPTOKINASE PERFUSION.
    MCNICOL GP; DOUGLAS AS
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:23-9. PubMed ID: 14199705
    [No Abstract]   [Full Text] [Related]  

  • 14. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 15. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The euglobulin method for estimation of fibrinolytic activity in streptokinase-activated plasma.
    BLIX S
    Scand J Clin Lab Invest; 1962; 14():528-32. PubMed ID: 13971659
    [No Abstract]   [Full Text] [Related]  

  • 17. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
    BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A
    Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen.
    HOPKINS TF; MEITES J
    Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684
    [No Abstract]   [Full Text] [Related]  

  • 19. STUDIES ON THE COAGULATION AND FIBRINOLYTIC SYSTEM IN LETHALLY IRRADIATED DOGS.
    WEGRZYNOWICZ Z; KOPEC M; LATALLO Z; KOWALSKI E
    Arch Immunol Ther Exp (Warsz); 1964; 12():524-33. PubMed ID: 14252035
    [No Abstract]   [Full Text] [Related]  

  • 20. [REVERSIBLE MODIFICATION OF ELECTROPHORETIC PROPERTIES OF BLOOD PROTEINS ACTIVATED BY UROKINASE IN VITRO].
    BULUK K; BIELAWIEC M; MALOFIEJEW M; KLENIEWSKI J
    Postepy Hig Med Dosw; 1963; 17():737-41. PubMed ID: 14125567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.